The lead nanobody, 4hD29, was radiolabelled and in vivo SPECT/CT imaging and biodistribution studies were performed in immunodeficient mice transplanted with DPP6-expressing Kelly neuroblastoma cells or insulin-producing human EndoC-βH1 cells. Here, INS is linked to neuroblastoma.